Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Sandostatin LAR 20mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) |
| BNF code | 0803043N0BBAGAG |
| Virtual Medicinal Product | Octreotide 20mg powder and solvent for suspension for injection vials |
| Name | Sandostatin LAR 20mg powder and solvent for suspension for injection vials |
| Abbreviated name | Sandostatin LAR 20mg inj vials |
| Date of name applicability | 9 Jun 2004 |
| Previous name | Sandostatin LAR 20mg injection vials and diluent |
| Supplier | Novartis Pharmaceuticals UK Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Intramuscular |
| Actual Medicinal Product Packs | |
| Sandostatin LAR 20mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) 1 vial | |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.